Trastuzumab deruxtecan shows results in controlling stable metastases in HER2-positive metastatic breast cancer
UCLA Jonsson Comprehensive Cancer Center researchers presented research at the San Antonio Breast Cancer Symposium showing that a subgroup analysis of a phase III study found consistent progression-free survival (PFS) and ...
Dec 10, 2021
0
2